What happens if you take too much Ozempic or Wegovy?

Health & Lifestyle
2474

Listen to article (english)

Translate to Spanish or other 102 languages!

Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes
Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss. Image for illustration purposes

Medical News Today

- Advertisement -
  • Poison control centers across the United States are witnessing a concerning increase in inquiries related to semaglutide, an injectable medication used for diabetes management and weight loss.
  • Reports of inadvertent overdoses have led to hospitalizations in some cases, with symptoms including intense nausea, vomiting and abdominal discomfort.
  • Data from America’s Poison Centers reveals a startling 15-fold increase in semaglutide-related calls between January and November, primarily attributed to dosage errors, amid concerns over the safety of compounded formulations of the drug.

Semaglutide, a glucagon-like peptide-1 receptor agonist or GLP-1 analog, gained approval from the Food and Drug Administration (FDA) in 2017.

The medicine is marketed as Ozempic for diabetes management and Wegovy for weight loss.

Folllow the link below to Medical News Today to read the full story:

- Advertisement -

https://www.medicalnewstoday.com/articles/what-happens-if-you-take-too-much-ozempic-or-wegovy

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Why are cases of HIV infections on the rise among girls?
Next article
Dr. Pedro Mego’s Mission to Combat Peripheral Artery Disease to Save Limbs

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -